Indegene IPO Details | GMP, Date, Price, Review

Indegene IPO Details ( Indegene Limited IPO Review )

(6 May 2024 – 8 May 2024)

Established in 1998, Indegene Limited offers digital solutions for the life sciences sector. They support various stages of drug development, clinical trials, regulatory submissions, pharmacovigilance, handling complaints, and assisting with sales and marketing.

Here are the main categories of services they provide:

1. Enterprise Commercial Solutions
2. Omnichannel Activation
3. Enterprise Medical Solutions
4. Enterprise Clinical Solutions and consulting services

A subsidiary of Indegene Limited, DT Associates Limited, operates under the brand “DT Consulting,” offering consultancy to life sciences firms to navigate digital transformations and enhance customer experiences.

In recognition of their efforts, the company was honored with the Platinum Level award at the 2023 Healthy Workplace Conference and Awards, presented by Arogya World India Trust and the Public Health Foundation of India.

By December 31, 2023, Indegene Limited was actively serving 65 clients.

The company’s global workforce, as of December 31, 2023, comprised 5,181 employees. Of these, 4,461 were based in India, 530 in North America, 105 in Europe, 73 in China, and 12 in other regions.

Indegene Limited IPO Competitive Strength

• Domain expertise in healthcare
• Robust digital capabilities and in-house developed technology portfolio
• Track record of establishing long-standing client relationships
• Global delivery model
• Experienced management and motivated talent pool supported by marquee investors
• Track record of creating value through acquisitions

Indegene IPO Financials Performance ( Results )

Indegene Limited Financial Information (Restated Consolidated)

All Amount in ₹ Lakhs

Period Ended	Total Assets	Total Revenue	PAT	Net Worth	Reserves	Borrowing
31-Mar-21	596.04	996.92	149.41	324.51	324.19	24.76
31-Mar-22	1,353.47	1,690.50	162.82	763.90	763.55	18.24
31-Mar-23	2,203.87	2,364.10	266.10	1,063.72	1,019.43	394.34
31-Dec-23	2,518.15	1,969.75	241.90	1,327.00	1,282.65	399.33

Objective of Indegene IPO Issue

• Repayment/prepayment of indebtedness of one of the Material Subsidiaries, ILSL Holdings, Inc.;
• Funding the capital expenditure requirements of the Company and one of the Material Subsidiaries, Indegene, Inc.; and
• General corporate purposes and inorganic growth.

Indegene IPO Basic Details

IPO Date	May 6, 2024 to May 8, 2024
Listing Date	Monday, May 13, 2024
Face Value	₹2 per share
Price	₹430 to ₹452 per share
Lot Size	33 Shares
Issue Size	40,746,891 shares of ₹2 (aggregating up to ₹1,841.76 Cr)
Fresh Issue	16,814,159 shares of ₹2 (aggregating up to ₹760.00 Cr)
Offer for Sale	23,932,732 shares of ₹2 (aggregating up to ₹1,081.76 Cr)
Employee Discount	Rs 30 per share
Issue Type	Book Built Issue IPO
Listing At	NSE, BSE
Share holding pre issue	222,435,091
Share holding post issue	239,249,250
Company Promoters	BCP Topco VII Pte. Ltd.

Indegene IPO Reservation

QIB Shares Offered	50% of the Net Issue
NII (HNI) Shares Offered	15% of the Net Issue
Retail Shares Offered	35% of the Net Issue

Indegene IPO Timetable

Indegene IPO will open on May 6, 2024 and close on May 8, 2024. You can join Indegene IPO at 10.00 A.M. to 5.00 p.m. Upto which mandate can be applied.

Event	Date
Opening Date	6 May 2024 (Monday)
Closing Date	8 May 2024 (Wednesday)
Basis of Allotment	9 May 2024 (Thursday)
Initiation of Refunds	10 May 2024 (Friday)
Credit of Shares to Demat	10 May 2024 (Friday)
Listing Date	13 May 2024 (Monday)
Deadline for UPI mandate confirmation	5 PM on 8 May 2024

Indegene IPO Lot Size

For retail investors in Indegene IPO, 33 shares will come in 1 lot or the minimum investment will be ₹14,916. Retail-individual investors can apply for up to 13 lots or the maximum investment will be ₹193,908.

Application	Lots	Shares	Amount
Retail (Min)	1	33	₹14,916
Retail (Max)	13	429	₹193,908
S-HNI (Min)	14	462	₹208,824
S-HNI (Max)	67	2,211	₹999,372
B-HNI (Min)	68	2,244	₹1,014,288

Indegene IPO Promoter Holding

The company’s promoters include BCP Topco VII Pte. Ltd..

Pre Issue Share Holding	30.71%
Post Issue Share Holding

Indegene Ltd IPO Key Performance Indicator ( Valuation )

In the table given below, all the figures have been told according to the latest financial year.

KPI	Values
Market Cap (₹ Cr.)	10814.07
Earning Per Share (EPS)	₹11.97 per Equity Share
Net Asset Value (NAV)	₹48.10 per Equity Share
P/E Ratio (P/E) (x)	37.78
Post P/E Ratio (P/E) (x)	33.53
Return on Net Worth (RoNW) (%)	18.23
Debt/Equity Ratio	0.30
Price/Book Value Ratio	7.55

Indegene IPO GMP Live Update, Kostak Rate day by day

Date	GMP	Kostak	Subject to
Today	₹240	–	–
2 May 2024	₹240	–	–

Indegene IPO Detail Video:

Indegene IPO Subscription Status (Bidding Detail)

The Indegene IPO on May 8, 2024 at 7:02:00 PM was subscribed 70.30 times, with the retail category being subscribed 7.86 times, the NII (Non-Institutional Investor) category being subscribed 55.91 times, QIB (Qualified-Institutional Buyers) category being subscribed 192.72 times.

Category	Subscription
QIB	192.72x
NII	55.91x
Retail	7.86x
Employee	6.62x
Total	70.30x

Indegene IPO Prospectus

Indegene IPO DRHP	Download
Indegene IPO RHP	Download
Indegene IPO Anchor Investors Details PDF	Download

Indegene IPO Rating

Our Rating

/5.0

Indegene Company Contact Information

Indegene Limited

Registered and Corporate Office: Aspen Block G4, 3rd Floor, Manyata Embassy Business Park, Outer Ring Road, Nagawara, Bengaluru 560 045, Karnataka, India
Tel: +91 80 4674 4567/ +91 80 4644 7777
Website: www.indegene.com
Contact person: Srishti Ramesh Kaushik, Company Secretary and Compliance Officer
E-mail: compliance.officer@indegene.com
Corporate Identity Number: U73100KA1998PLC102040
Our Company is a Professionally Managed Company and Does Not Have an Identifiable Promoter

Indegene IPO Registrar

Link Intime India Private Limited

Registered Office: C-101, 1st Floor, 247 Park L.B.S. Marg, Vikhroli West Mumbai, 400 083, Maharashtra, India
Tel: +91 810 811 4949
E-mail: indegene.ipo@linkintime.co.in
Website: www.linkintime.co.in
Investor grievance email: indegene.ipo@linkintime.co.in
Contact person: Shanti Gopalkrishnan
SEBI Registration Number: INR000004058

Indegene IPO Lead Manager

Kotak Mahindra Capital Company Limited

Registered Office: 27BKC, 1st Floor, Plot No. C – 27 ”G” Block, Bandra Kurla Complex Bandra (East), Mumbai 400051, Maharashtra, India
Tel: +91 22 4336 0000
E-mail: indegene.ipo@kotak.com
Website: https://investmentbank.kotak.com
Investor grievance email: kmccredressal@kotak.com
Contact person: Ganesh Rane
SEBI Registration Number: INM000008704

Citigroup Global Markets India Private Limited

Registered Office: 1202, 12th Floor, First International Financial Center, G-Block, C54 & 55, Bandra Kurla Complex, Bandra (East), Mumbai 400 098, Maharashtra, India
Tel: +91 22 6175 9999
E-mail: indegene.ipo@citi.com
Website: www.online.citibank.co.in
Investor grievance email: investors.cgmib@citi.com
Contact person: Huzefa Bodabhaiwala
SEBI Registration Number: INM000010718

J.P. Morgan India Private Limited

Registered Office: J.P. Morgan Tower, Off. C.S.T. Road Kalina, Santacruz (East), Mumbai 400 098, Maharashtra, India
Tel: +91 22 6157 3000
E-mail: INDEGENE_IPO@jpmorgan.com
Website: www.jpmipl.com
Investor grievance email: investorsmb.jpmipl@jpmorgan.com
Contact person: Nidhi Wangnoo/Saarthak K. Soni
SEBI Registration Number: INM000002970

Nomura Financial Advisory and Securities (India) Private Limited

Registered Office: Ceejay House, Level 11 Plot F, Shivsagar Estate Dr. Annie Besant Road, Worli Mumbai 400 018, Maharashtra, India
Tel: +91 22 4037 4037
E-mail: indegeneipo@nomura.com
Website: www.nomuraholdings.com/company/group/asia/india/index.html
Investor Grievance E-mail: Investorgrievances-in@nomura.com
Contact person: Vishal Kanjani/Kshitij Thakur
SEBI Registration Number: INM000011419

Indegene IPO FAQs